TRCT
TRIV

Tower Research Capital (TRC)’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Tower Research Capital (TRC)’s Portfolio TRIV Stock Details TRIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-785
Closed -$6K – 5678
2015
Q4 		$6K Sell
785
-506
-39% -$3.35K ﹤0.01% 2904
2015
Q3 		$6K Buy
1,291
+886
+219% +$4.76K ﹤0.01% 2745
2015
Q2 		$2K Buy
405
+305
+305% +$2.16K ﹤0.01% 3892
2015
Q1 		$1K Sell
100
-48
-32% -$495 ﹤0.01% 4287
2014
Q4 		$2K Sell
148
-6,902
-98% -$94.1K ﹤0.01% 3511
2014
Q3 		$102K Buy
7,050
+1,507
+27% +$21.9K 0.01% 930
2014
Q2 		$87K Buy
+5,543
New +$84.1K 0.01% 982

Tower Research Capital (TRC)'s TRIV Position: Q1 2016 in Review

Tower Research Capital (TRC) sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q1 2016, closing a stake of 785 shares — an estimated $6K sold.

Tower Research Capital (TRC) first reported a position in TRIV in Q2 2014 and held it in 7 quarters. The position peaked at $102K in Q3 2014. 0 funds tracked by Wall St. Rank hold TRIV as of Q1 2016.

  • Tower Research Capital (TRC) reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 785 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q1 2016, an estimated $6K.
  • Tower Research Capital (TRC) first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 7 quarters.
  • Tower Research Capital (TRC)'s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $102K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q1 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2016, filed 16 May 2016.